Imcheck Therapeutics raised €49M in a Series B round in Oct 2019. The company is based in Marseille, France. Investors in the round: Bpifrance, Pfizer Venture Investments. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
